Coherus Oncology, Inc. Marketable Securities (Current)
Coherus Oncology, Inc. (CHRS) had Marketable Securities (Current) of $22.38 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:MarketableSecuritiesCurrent · last filed 2026-08-05
- 2026-06-30: Marketable Securities, Current $22.38M.
- 2026-03-31: Marketable Securities, Current $51.81M.
- 2025-12-31: Marketable Securities, Current $83.25M.
- 2025-09-30: Marketable Securities, Current $88.31M.
| Period end | Marketable Securities, Current |
|---|---|
| 2026-06-30 | $22.38M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $51.81M 10-Q · filed 2026-05-11 |
| 2025-12-31 | $83.25M 10-Q · filed 2026-08-05 |
| 2025-09-30 | $88.31M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $20.74M 10-Q · filed 2025-08-07 |
| 2023-12-31 | $14.86M 8-K · filed 2025-11-13 |
| 2023-09-30 | $50.82M 10-Q · filed 2023-11-06 |
| 2023-06-30 | $71.79M 10-Q · filed 2023-08-02 |
| 2023-03-31 | $111.94M 10-Q · filed 2023-05-08 |
| 2022-12-31 | $128.13M 10-K · filed 2024-03-15 |
| 2021-09-30 | $108.17M 10-Q · filed 2021-11-08 |
| 2021-06-30 | $124.68M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $140.01M 10-Q · filed 2021-05-06 |
| 2020-09-30 | $210.97M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $231.88M 10-Q · filed 2020-08-06 |
| 2019-12-31 | $0.00 10-Q · filed 2020-08-06 |
| 2019-09-30 | $5.38M 10-Q · filed 2019-11-08 |
| 2019-06-30 | $5.99M 10-Q · filed 2019-08-05 |
| 2019-03-31 | $14.92M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $0.00 10-Q · filed 2019-11-08 |
| 2018-09-30 | $15.97M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $29.81M 10-Q · filed 2018-08-08 |
| 2018-03-31 | $13.14M 10-Q · filed 2018-05-10 |
| 2017-09-30 | $14.49M 10-Q · filed 2017-11-06 |
| 2017-06-30 | $44.98M 10-Q · filed 2017-08-07 |
| 2017-03-31 | $49.90M 10-Q · filed 2017-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |